Pneumococcal polysaccharide vaccine in high risk adults

BMJ (Online)

Volumn 340, Issue 7746, 2010, Pages 543-

  Moberley, Sarah A ^a   Torzillo, Paul ^a,b  

^a PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS POLYSACCHARIDE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; EDITORIAL; EVIDENCE BASED PRACTICE; HUMAN; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

ADULT; HUMANS; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 77949377353     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c1139     Document Type: Editorial

References (8)

1. Maruyama T, Taguchi O, Neiderman N, Morser J, Kobayashi H, Kobayashi T, et al. Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial. BMJ 2010;340:c1004. [Abstract/Free Full Text]
2. MacLeod C HR, Heidelberger M, Berhard WG. Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides. J Exp Med 1945;82:445-65.[Abstract]
3. Austrian R, Douglas RM, Schiffman G, Coetzee AM, Koornhof HJ, Hayden-Smith S, et al. Prevention of pneumococcal pneumonia by vaccination. Trans Assoc Am Physicians 1976;89:184-92.[Medline]
4. Smit P, Oberholzer D, Hayden-Smith S, Koornhof H, Hilleman M. Protective efficacy of pneumococcal polysaccharide vaccines. JAMA 1977;238:2613-6.[Abstract/Free Full Text]
5. Riley ID, Andrews M, Howard R, Tarr PI, Pfeiffer M, Challands P, et al. Immunization with polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea highlands community. Lancet 1977;309:1338-41.[CrossRef]
6. Robbins JB, Austrian R, Lee CJ, Rastogi SC, Schiffman G, Henrichsen J, et al. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis 1983;148:1136-59.[Web of Science][Medline]
7. Moberley S, Holden J, Tatham D, Andrews R. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008;(1):CD000422.
8. Huss A, Scott P, Stuck AE, Trotter C, Egger M. Efficacy of pneumococcal vaccination in adults: a meta-analysis. Can Med Assoc J 2009;180:48-58.[Abstract/Free Full Text]